| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $391.9M | -3.2% |
| Cost of Revenue | $306.2M | -6.8% |
| Gross Profit | $85.7M | +11.9% |
| R&D Expense | $4.4M | -4.3% |
| SG&A Expense | $48.1M | -1.2% |
| Operating Income | $30.1M | +616.7% |
| Pre-tax Income | $26.5M | +373.2% |
| Income Tax | $8.2M | +215.5% |
| Net Income | $18.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | +78.3% |
| Accounts Receivable | $45.8M | -12.4% |
| Inventory | $83.6M | -12.8% |
| Current Assets | $175.8M | +4.1% |
| Total Assets | $382.4M | +2.8% |
| Current Liabilities | $93.7M | +44.6% |
| Long-term Debt | $45.1M | -37.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.1M | +94.3% |
| Capital Expenditures | $10.3M | +9.6% |
| Investing Cash Flow | -$3.4M | +64.2% |
| Financing Cash Flow | -$44.0M | -60.0% |
| Free Cash Flow | $40.8M | +141.4% |
| +1068.4% |
| EPS (Basic) | $0.69 | +1085.7% |
| EPS (Diluted) | $0.68 | +1071.4% |
| Total Liabilities |
| $162.9M |
| +2.1% |
| Stockholders' Equity | $219.5M | +3.2% |